Extended Data Fig. 2: TLR9-MyD88 signaling promotes disease.

a-e, Evaluation of the clinical parameters separated by gender (Tlr9−/− male, n = 21; Tlr9P915H/P915H male, n = 37; Tlr9+/− male, n = 24; Tlr9−/− female, n = 22; Tlr9P915H/P915H female, n = 25; Tlr9+/− female, n = 28; (a, female) Tlr9−/− versus Tlr9P915H/P915H p = 0.0022, Tlr9−/− versus Tlr9+/− p = 0.0431; (b) Tlr9−/− versus Tlr9P915H/P915H p < 0.0001, Tlr9P915H/P915H versus Tlr9+/− p = 0.0005; (c) Tlr9−/− versus Tlr9P915H/P915H p = 0.0007, Tlr9P915H/P915H versus Tlr9+/− p = 0.0445; (d) Tlr9−/− versus Tlr9P915H/P915H p < 0.0001, Tlr9P915H/P915H versus Tlr9+/− p = 0.0005; (e) Tlr9P915H/P915H versus Tlr9+/− p = 0.0521) f, Percent TCR−CD19+ B cells of live splenocytes in male and female mice of the indicated genotypes (Tlr9−/−, n = 36; Tlr9P915H/P915H, n = 55; Tlr9+/−, n = 44; Tlr9−/− versus Tlr9+/− p = 0.0260). g-h, Percent CD21hi CD23lo MZ (Tlr9−/−, n = 36; Tlr9P915H/P915H, n = 55; Tlr9+/−, n = 44), and CD11b+ CD11c+ ABC of live B cells in mice of the indicated genotypes (Tlr9−/−, n = 36; Tlr9P915H/P915H, n = 53; Tlr9+/−, n = 41; (g) Tlr9−/− versus Tlr9P915H/P915H p = 0.0109, Tlr9P915H/P915H versus Tlr9+/− p = 0.0032; (h) Tlr9−/− versus Tlr9P915H/P915H p = 0.0228). i, Percent TCR−CD44hiCD138hi plasmablasts of live splenocytes in mice of the indicated genotypes (Tlr9−/−, n = 36; Tlr9P915H/P915H, n = 55; Tlr9+/−, n = 44; Tlr9−/− versus Tlr9P915H/P915H p = 0.0264). j, Percent TCR+CD4+ and TCR+CD8+ cells of live splenocytes in male and female mice of the indicated genotypes (Tlr9−/−, n = 36; Tlr9P915H/P915H, n = 52; Tlr9+/−, n = 44; CD4+, Tlr9−/− versus Tlr9P915H/P915H p = 0.0047, Tlr9P915H/P915H versus Tlr9+/− p = 0.0131; CD8+, Tlr9−/− versus Tlr9P915H/P915H p = 0.0001, Tlr9P915H/P915H versus Tlr9+/− p = 0.0005). k-l, Percent naïve (CD62Lhi CD44lo), activated (CD62Lhi CD44hi) and memory (CD62Llo CD44hi) of CD4 and CD8 splenocytes (Tlr9−/−, n = 36; Tlr9P915H/P915H, n = 52; Tlr9+/−, n = 44, (k) naïve Tlr9−/− versus Tlr9P915H/P915H p < 0.0001, Tlr9P915H/P915H versus Tlr9+/− p = 0.0018; activated Tlr9−/− versus Tlr9P915H/P915H p = 0.0345; (l) activated Tlr9−/− versus Tlr9P915H/P915H p = 0.0324, Tlr9P915H/P915H versus Tlr9+/− p = 0.0034; memory Tlr9−/− versus Tlr9P915H/P915H p = 0.0013, Tlr9P915H/P915H versus Tlr9+/− p = 0.0006). (a-l, For all panels, data points indicate individual mice and bars the mean ± SEM. For statistics in (a-l) * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001, one-way ANOVA with Tukey’s multiple comparisons test).